BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 37427139)

  • 1. Recent advances in nanomedicine preparative methods and their therapeutic potential for colorectal cancer: a critical review.
    Jain A; Bhattacharya S
    Front Oncol; 2023; 13():1211603. PubMed ID: 37427139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A shift in focus towards precision oncology, driven by revolutionary nanodiagnostics; revealing mysterious pathways in colorectal carcinogenesis.
    Sharma S; Bhattacharya S; Joshi K; Singh S
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16157-16177. PubMed ID: 37650995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.
    Kasi PB; Mallela VR; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.
    Wang K; Shen R; Meng T; Hu F; Yuan H
    Molecules; 2022 May; 27(9):. PubMed ID: 35566331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology a Boon for Colorectal Cancer Treatment.
    Kriplani P; Guarve K
    Recent Pat Anticancer Drug Discov; 2023; 18(3):379-396. PubMed ID: 36221866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
    Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
    Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyphenol-Based Nanoparticles: A Promising Frontier for Enhanced Colorectal Cancer Treatment.
    Wahnou H; Liagre B; Sol V; El Attar H; Attar R; Oudghiri M; Duval RE; Limami Y
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of the Recent Developments and Patents in the Field of Pharmaceutical Nanotechnology.
    Purohit D; Manchanda D; Makhija M; Rathi J; Verma R; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2021; 15(1):15-34. PubMed ID: 32912128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles: Attractive tools to treat colorectal cancer.
    Younis NK; Roumieh R; Bassil EP; Ghoubaira JA; Kobeissy F; Eid AH
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):1-13. PubMed ID: 36028154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review.
    Shazleen Ibrahim I; Starlin Chellathurai M; Mahmood S; Hakim Azmi A; Harun N; Ulul Ilmie Ahmad Nazri M; Muzamir Mahat M; Mohamed Sofian Z
    Int J Pharm; 2024 Feb; 651():123735. PubMed ID: 38142874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micelles as potential drug delivery systems for colorectal cancer treatment.
    Fatfat Z; Fatfat M; Gali-Muhtasib H
    World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
    Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
    World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment.
    Xu M; Li S
    Cancer Lett; 2023 Oct; 574():216397. PubMed ID: 37730105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research advances in nanomedicine applied to the systemic treatment of colorectal cancer.
    Yin L; Li H; Shi L; Chen K; Pan H; Han W
    Int J Cancer; 2023 Mar; 152(5):807-821. PubMed ID: 35984398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome technologies towards colorectal cancer therapeutics.
    Sang R; Stratton B; Engel A; Deng W
    Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles Containing Oxaliplatin and the Treatment of Colorectal Cancer.
    Mahaki H; Mansourian M; Meshkat Z; Avan A; Shafiee MH; Mahmoudian RA; Ghorbani E; Ferns GA; Manoochehri H; Menbari S; Sheykhhasan M; Tanzadehpanah H
    Curr Pharm Des; 2023; 29(38):3018-3039. PubMed ID: 37990895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the salting-out technique on the preparation of colloidal particulate systems for pharmaceutical applications.
    Mendoza-Muñoz N; Quintanar-Guerrero D; Allémann E
    Recent Pat Drug Deliv Formul; 2012 Dec; 6(3):236-49. PubMed ID: 22734871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs.
    Sabit H; Abdel-Hakeem M; Shoala T; Abdel-Ghany S; Abdel-Latif MM; Almulhim J; Mansy M
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.